Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2)

Published:2024-09 Issue: Volume:16 Page:163-174
ISSN:2666-3287
Container-title:JAAD International
language:en
Short-container-title:JAAD International

Author:

Yosipovitch Gil,Kim Brian S.,Kwatra Shawn G.,Mollanazar Nicholas K.,Ständer Sonja,Satoh Takahiro,Mendes-Bastos Pedro,Tsai Tsen-Fang,Laws Elizabeth,Nivens Michael C.,Maloney Jennifer,Shi Genming,Bansal Ashish,Dubost-Brama Ariane

Funder

Regeneron Pharmaceuticals Inc

Sanofi US

Publisher

Elsevier BV

Reference34 articles.

1. Clinical characteristics and disease burden in prurigo nodularis;Aggarwal;Clin Exp Dermatol,2021

2. Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus;Elmariah;J Am Acad Dermatol,2021

3. Health-related quality of life and economic burden of prurigo nodularis;Whang;J Am Acad Dermatol,2022

4. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: results of the European Academy of Dermatology and Venereology network on assessment of severity and burden of pruritus (PruNet) cross-sectional trial;Steinke;J Am Acad Dermatol,2018

5. The burden in chronic prurigo: patients with chronic prurigo suffer more than patients with chronic pruritus on non-lesional skin: a comparative, retrospective, explorative statistical analysis of 4,484 patients in a real-world cohort;Zeidler;J Eur Acad Dermatol Venereol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP